Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues - Fierce Biotech
Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues Fierce Biotech
Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues Fierce Biotech
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.